Mounjaro is a new prescription medicine that was approved by MHRA in November 2023 to help manage weight in adults living with obesity.
How does Mounjaro® work?
The active ingredient, tirzepatide, activates two hormonal receptors GLP-1 (glucagon- like peptide-1) and GIP (Gastric inhibitory polypeptide). When these hormones are mimicked
Your appetite is supressed.
Your blood sugar is better regulated, helping you feel fuller for longer
Food leaves your stomach slower; digestion is slowed allowing you to eat smaller portions
It’s worth noting that Mounjaro alone isn’t a suitable treatment for obesity, nor is it a replacement for a healthy lifestyle. It should always be used together with a balanced diet and regular exercise.